H1B Salary Data

Home › Employers › Clinical Reference Laboratory, Inc

Clinical Reference Laboratory, Inc: H-1B salaries and sponsorship

Clinical Reference Laboratory, Inc filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $78,911.

Applications (LCAs)3
Certified3
Employer addressLenexa, KS
H-1B dependent employerNo
Median offered salary$78,911
Middle half of salaries$77,394–$80,884
10th–90th percentile$76,483–$82,068

Does Clinical Reference Laboratory, Inc sponsor H-1B visas?

Clinical Reference Laboratory, Inc filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on May 12, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Development Operations and Release Quality Engineer3$78,911

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20251$75,876
FY20262$80,884

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Development Operations and Release Quality Engineer$82,857
Level I		Lenexa, KSMay 12, 2026Nov 10, 2026Certified
Development Operations and Release Quality Engineer$78,911
Level I		Lenexa, KSJan 7, 2026Jul 6, 2026Certified
Development Operations and Release Quality Engineer$75,876
Level I		Lenexa, KSJan 27, 2025Jul 25, 2025Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).